1203669-89-9

Basic information

• Product Name: 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-amino-6''-deoxy-kanamycin A
• Synonyms: 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-amino-6''-deoxy-kanamycin A
• CAS NO: 1203669-89-9
• Molecular Weight: 883.989
• Mol File: 1203669-89-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-amino-6''-deoxy-kanamycin A(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-amino-6''-deoxy-kanamycin A(1203669-89-9)
• EPA Substance Registry System: 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-amino-6''-deoxy-kanamycin A(1203669-89-9)

Safety Data

• Hazardous Substances Data: 1203669-89-9(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 59-01-8 kanamycin A 
• 953395-49-8 6''-(2,4,6-triisopropylbenzenesulfonyl)-1,3,6',3''-tetra-N-(tert-butoxycarbonyl)kanamycin A 
• 953395-50-1 1,3,6',3''-tetra-N-(tert-butoxycarbonyl)-6''-azido-6''-deoxy-kanamycin A 
• 80860-34-0 di-tert-butyl ((1S,3R,4S,5R,6R)-4-(((2S,3R,4S,5S,6R)-4-((tert-butoxycarbonyl)amino)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(((2R,3R,4S,5S,6R)-6-(((tert-butoxycarbonyl)amino)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-5-hydroxycyclohexane-1,3-diyl)dicarbamate 

Relevant articles and documents

Rapid solid-phase syntheses of a peptidic-aminoglycoside library

A library of mono- and di-amino acid peptidic-aminoglycosides (PAs), with kanamycin and neomycin as the model aminoglycosides, was systematically and rapidly synthesized via solid phase peptide synthesis. Aminoglycosides were first converted into N-Boc pr

GUANIDINYLATED AMINOGLYCOSIDE-LIPID CONJUGATES

Guanadinylated aminoglycoside-lipid conjugates are prepared. Such conjugates may comprise an aminoglycoside such as an aminoglyucoside antibiotic like neomycin or kanamycin, at least one guanidino group attached to a primary or secondary carbon atom of the aminoglyucoside group and at least one lipid group attached through a bond or a linker to a branched carbon atom of the aminoglycoside. These conjugates exhibit improve antibacterial activity and may be used in conjunction with another antibiotic.